化学
二氢叶酸还原酶
吉非替尼
IC50型
生长抑制
胸苷酸合酶
立体化学
喹啉酮
表皮生长因子受体
表皮生长因子受体抑制剂
细胞生长
体外
酶
生物化学
受体
癌症
生物
遗传学
氟尿嘧啶
作者
Yomna I. El‐Gazzar,Heba R. Ghaiad,Ahmed Mahmoud El Kerdawy,Riham F. George,Hanan Hanna Georgey,Khairia M. Youssef,Hussein I. El‐Subbagh
标识
DOI:10.1002/ardp.202200417
摘要
Abstract New 2‐mercapto‐quinazolin‐4‐one analogs were synthesized and tested for their in vitro anticancer activity, dihydrofolate reductase (DHFR) inhibition, and epidermal growth factor tyrosine kinase (EGFR‐TK) inhibition activities. Compound24, which is characterized by a 2‐benzyl‐thio function, showed broad‐spectrum anticancer activity with high safety profile and selectivity index. The concentrations of24causing 50% growth inhibition (GI50) and total cell growth inhibition (TGI) and its lethal concentration 50 (LC50) were 15.1, 52.5, and 91.2 µM, respectively, using 5‐fluorouracil as a positive control. Also, it showed EGFR‐TK inhibitory activity with IC50 = 13.40 nM compared to gefitinib (IC50 = 18.14 nM) and DHFR inhibitory potency with 0.30 μM compared to methotrexate (MTX; IC50 = 0.08 μM). In addition, compound24caused cell cycle arrest and apoptosis on COLO‐205 colon cancer cells. Compounds37, 21, and54showed remarkable DHFR inhibitory activity with IC50values of 0.03, 0.08, and 0.08 μM, respectively. The inhibitory properties of these compounds are due to an electron‐withdrawing group on the quinazolinone ring, except for compound54. In a molecular modeling study, compound24showed the same binding mode as gefitinib as it interacted with the amino acid Lys745 via π–π interaction. Compound37showed a similar binding mode as MTX through the binding interaction with Lys68, Asn64 via hydrogen bond acceptor, and Phe31 via arene–arene interaction. The obtained model and substitution pattern could be used for further development.
科研通智能强力驱动
Strongly Powered by AbleSci AI